BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27174201)

  • 21. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations.
    Salci KR; Lee JH; Laronde S; Dingwall S; Kushwah R; Fiebig-Comyn A; Leber B; Foley R; Dal Cin A; Bhatia M
    Stem Cells; 2015 Jun; 33(6):1839-49. PubMed ID: 25764124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors.
    Wen W; Zhang JP; Chen W; Arakaki C; Li X; Baylink D; Botimer GD; Xu J; Yuan W; Cheng T; Zhang XB
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.
    Varga E; Nemes C; Davis RP; Ujhelly O; Klincumhom N; Polgar Z; Muenthaisong S; Pirity MK; Dinnyes A
    Exp Cell Res; 2014 Apr; 322(2):335-44. PubMed ID: 24560743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation and characterization of induced pluripotent stem cell line IITGi001-A derived from adult human primary dermal fibroblasts.
    Raina K; Joshi G; Modak K; Premkumar C; Priyanka S; Rajesh P; Velayudhan SR; Thummer RP
    Stem Cell Res; 2023 Sep; 71():103159. PubMed ID: 37392703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of integration-free induced pluripotent stem cells from human recessive dystrophic epidermolysis bullosa keratinocytes.
    Matsumura W; Fujita Y; Nakayama C; Shinkuma S; Suzuki S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Mar; 89(3):263-271. PubMed ID: 29229433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
    Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
    Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
    Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Galat V; Galat Y; Perepitchka M; Jennings LJ; Iannaccone PM; Hendrix MJ
    Stem Cells Dev; 2016 Jul; 25(14):1060-72. PubMed ID: 27193052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy.
    Navarro S; Moleiro V; Molina-Estevez FJ; Lozano ML; Chinchon R; Almarza E; Quintana-Bustamante O; Mostoslavsky G; Maetzig T; Galla M; Heinz N; Schiedlmeier B; Torres Y; Modlich U; Samper E; Río P; Segovia JC; Raya A; Güenechea G; Izpisua-Belmonte JC; Bueren JA
    Stem Cells; 2014 Feb; 32(2):436-46. PubMed ID: 24420904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
    Hwang Y; Broxmeyer HE; Lee MR
    Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient induction of pluripotent stem cells from menstrual blood.
    Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
    Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells.
    Geti I; Ormiston ML; Rouhani F; Toshner M; Movassagh M; Nichols J; Mansfield W; Southwood M; Bradley A; Rana AA; Vallier L; Morrell NW
    Stem Cells Transl Med; 2012 Dec; 1(12):855-65. PubMed ID: 23283547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.
    Barrett R; Ornelas L; Yeager N; Mandefro B; Sahabian A; Lenaeus L; Targan SR; Svendsen CN; Sareen D
    Stem Cells Transl Med; 2014 Dec; 3(12):1429-34. PubMed ID: 25298370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors.
    Su RJ; Baylink DJ; Neises A; Kiroyan JB; Meng X; Payne KJ; Tschudy-Seney B; Duan Y; Appleby N; Kearns-Jonker M; Gridley DS; Wang J; Lau KH; Zhang XB
    PLoS One; 2013; 8(5):e64496. PubMed ID: 23704989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
    Lieu PT
    Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
    M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
    Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.